Immunosuppressants, immunomodulators and COVID-19 vaccines: anticipating patient concerns

This publication has 15 references indexed in Scilit:

• Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
  New England Journal of Medicine, 2020
• Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies
  Vaccines, 2020
• Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al
  Annals of the Rheumatic Diseases, 2020
• mRNA vaccines — a new era in vaccinology
  Nature Reviews Drug Discovery, 2018
• Response to Tetanus and Pneumococcal Vaccination Following Administration of Ixekizumab in Healthy Participants
  BioDrugs, 2017
• Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial
  Annals of the Rheumatic Diseases, 2017
• Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay
  Pediatric Rheumatology, 2017
• Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine
  Vaccine, 2017
• Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases – a longitudinal study
  Arthritis Research & Therapy, 2015
• Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
  Arthritis Research & Therapy, 2013